COVID-19 Virus Infection and Transmission are Observably Less in Highly Dengue-endemic Countries: Can Dengue Vaccines be “Repurposed” to Prevent COVID-19?

Subhajit Biswas; Soumi Sukla

doi:10.20944/preprints202004.0040.v3

Comment 1

Received: 5 May 2020
Commenter: Subhajit Biswas
Commenter's Conflict of Interests: Author

Comment: We have elaborated on the abstract part and made some editings in the main text to enhance clarity.

+ Respond to this comment

Comment 2

Received: 20 June 2020
Commenter:

Subhajit Biswas

The commenter has declared there is no conflict of interests.

Comment: In connection to this research, we have done computational analysis on possibilities of interaction between Dengue virus antibodies and SARS-CoV-2 virus and came up with results that further support our hypothesis.

You can read our analysis online, and let us know your comments.

Title of publication: Computational modelling predicts that Dengue virus antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?

(Link: https://osf.io/dutx4)

On the basis of our observations that COVID-19 and Dengue severity maps do not tend to overlap and the fact that serological cross-reactivity has been reported for COVID-19 antibodies with Dengue antigen (s), together with results from our computational studies, we are of opinion that serology-based diagnosis needs to be complemented with NAT/virus antigen detection-based tests for definitive diagnosis/sero-surveillance of either disease in regions where both of these viruses are now co-existent.

+ Respond to this comment

Comment 3

Received: 14 July 2020
The commenter has declared there is no conflict of interests.

Comment: Our pilot level results emphasize the importance of NAT and/or virus antigen tests to complement sero-surveillance for definitive diagnosis of COVID-19/Dengue in regions where both viruses are co-endemic.

Please read our latest findings:

Dengue antibodies can cross-react with SARS-CoV-2 and vice versa-Antibody detection kits can give false-positive results for both viruses in regions where both COVID-19 and Dengue co-exist.

https://www.medrxiv.org/content/10.1101/2020.07.03.20145797v1.article-metrics
Authors.

+ Respond to this comment

Not displayed online.

Please leave your comment to this article below.

Mathematical equations can be typed in either LaTeX formats \\[ ... \\] or $$ ... $$, or MathML format <math> ... </math>. Try the LaTeX or MathML example.

Type equation:

Preview:

Copy equation into message below

Close menu

Please click a symbol to insert it into the message box below:

Please enter the link here:

Optionally, you can enter text that should appear as linked text:

Copy link into message below

Please enter or paste the URL to the image here (please only use links to jpg/jpeg, png and gif images):

Copy image into message below

Type author name or keywords to filter the list of references in this group (you can add a new citation under Bibliography):

No existing citations in Discussion Group

Wikify editor is a simple editor for wiki-style mark-up. It was written by MDPI for Sciforum in 2014. The rendering of the mark-up is based on Wiky.php with some tweaks. Rendering of mathematical equations is done with MathJax. Please send us a message for support or for reporting bugs.

Please declare any conflicts of interest you may have with this paper, financial or otherwise.

I do not have a conflict of interest

I would like to declare a conflict of interest

Display my name on the website

Captcha

Renew

I accept the following conditions:

Comments must follow the standards of professional discourse and should focus on the scientific content of the article. Insulting or offensive language, personal attacks and off-topic remarks will not be permitted. Comments must be written in English. Preprints reserves the right to remove comments without notice. Readers who post comments are obliged to declare any competing interests, financial or otherwise.

COVID-19 Virus Infection and Transmission are Observably Less in Highly Dengue-endemic Countries: Can Dengue Vaccines be “Repurposed” to Prevent COVID-19?

Abstract

Keywords

Subject

Comments (3)